A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
Conditions
Heterozygous Familial Hypercholesterolemia · Premature Coronary Heart Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Clinical Study Center, Dothan, Alabama, United States
Clinical Study Center, Pomona, California, United States
Clinical Study Center, Boca Raton, Florida, United States
Clinical Study Center, Jacksonville, Florida, United States
Clinical Study Center, Winter Park, Florida, United States
Clinical Study Center, High Point, North Carolina, United States
Clinical Study Center, DeSoto, Texas, United States
Clinical Study Center, Renton, Washington, United States
Clinical Study Center, Adelaide, Australia
Clinical Study Center, Melbourne, Australia
Clinical Study Center, Sydney, Australia
Clinical Study Center, Chicoutimi, Canada
Clinical Study Center, Hamilton, Canada
Clinical Study Center, Montreal, Canada
Clinical Study Center, Québec, Canada
Clinical Study Center, Toronto, Canada
Clinical Study Center, Vancouver, Canada
Clinical Study Center, Rehovot, Israel
Clinical Study Center, Christchurch, New Zealand
Clinical Study Center, Birmingham, United Kingdom
Clinical Study Center, Edinburgh, United Kingdom
Clinical Study Center, London, United Kingdom
Clinical Study Center, Manchester, United Kingdom
Clinical Study Center, Nottingham, United Kingdom
Study leads
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company